(1R,2R)-2-((R)-1-phenylethylamino)cyclohexanol, 98%, 250mg

3- tert -Butoxycarbonylamino-3-(4-chloro-phenyl)-propionic acid, 97.0%, 5g

2-(4-Methoxycyclohexyl)ethylamine (cis- and trans- mixture)>98.0%(GC)(T)5g

Tert-butyl 4-(4-chlorobenzyl)-4-cyanopiperidine-1-carboxylate, 98%, 500mg

7-Methyl-2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-sulfonyl chloride, 100mg

(R)-2-(Aminomethyl)-4-methylpentanoic acid, 95.0%, 100mg

2-(2,6-Dichlorobenzoyl)-5-(1,3-dioxolan-2-yl)thiophene, 97.0%, 1g

(1S,2S,4S,5S)-2,5-Bis(3,5-di-tert-butyl-2-hydroxybenzylideneamino)bicyclo[2.2.1]heptane>98.0%(HPLC)(N)100mg

trans-Benzyl 3-fluoro-4-hydroxypiperidine-1-carboxylate, 5g

4-Bromo-6-(trifluoromethyl)pyrimidine, 95.0%, 5g

Rhodamine 123, 99.73%, 1g

2,8-Dimethyl-quinoline-3-carboxylic acid, 95.0%, 1g

Hyperoside, ROTICHROM® TLC, 100 mg, glass packaging